Results 21 to 30 of about 4,514 (233)
Aims To detect the expression of autophagy components, p38 MAPK (p38) and phosphorylated forkhead box transcription factor O-1 (pFoxO1) in pulmonary vascular endothelial cells of chronic thromboembolic pulmonary hypertension (CTEPH) rats and to ...
Dawen Wu +8 more
doaj +2 more sources
Endothelial Features Along the Pulmonary Vascular Tree in Chronic Thromboembolic Pulmonary Hypertension: Distinctive or Shared Facets? [PDF]
ABSTRACT Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare complication of pulmonary embolism, characterized by the presence of organized fibro‐thrombotic material that partially or fully obstructs the lumen of large pulmonary arteries, microvasculopathy, and enlargement of the bronchial systemic vessels. The precise mechanisms underlying
Verhaegen J +8 more
europepmc +2 more sources
Endometrial Changes Associated with Mifepristone: A Review. [PDF]
Mifepristone is a well-established pharmaceutical agent in obstetrics and gynecology, which has expanded its therapeutic applications to Cushing’s syndrome, meningioma, and even mental disease.
Lin Q, Zhou Y.
europepmc +2 more sources
Chloroquine Restores eNOS Signaling in Shunt Endothelial Cells via Inhibiting eNOS Uncoupling. [PDF]
Pulmonary arterial hypertension (PAH) is characterized by increased lung vascular stiffness and impaired vessel relaxation, primarily due to reduced nitric oxide (NO) production in endothelial cells. Recent studies indicate that chloroquine, an autophagy
Liang Y +11 more
europepmc +2 more sources
Methamphetamine-Associated Pulmonary Arterial Hypertension: Impact, Mechanisms, and a Framework for Management. [PDF]
ABSTRACT Methamphetamine‐associated pulmonary arterial hypertension (Meth‐PAH) is an increasingly prevalent but understudied subtype of Group 1 pulmonary arterial hypertension (PAH). While most prevalent in the Western United States, its reach continues to expand with the evolving global methamphetamine epidemic.
Sood N +4 more
europepmc +2 more sources
Ulipristal acetate (UPA) is effective in the treatment of uterine fibroids. However, its clinical use is hampered by the development of pathologic progesterone receptor modulator-associated endometrial changes (PAECs).
Marwa S. Hamza +2 more
doaj +1 more source
Background This study was to determine the molecular mechanism of miR‐144‐3p in the treatment of pulmonary arterial hypertension (PAH). Methods Luciferase assays detected the binding site of miR‐144‐3p. Quantitative reverse transcription‐polymerase chain
Chao Shi +4 more
doaj +1 more source
MicroRNA-483 amelioration of experimental pulmonary hypertension. [PDF]
Endothelial dysfunction is critically involved in the pathogenesis of pulmonary arterial hypertension (PAH) and that exogenously administered microRNA may be of therapeutic benefit.
Bai, Liang +22 more
core +1 more source
Background: The hypoxia-induced pro-proliferative and anti-apoptotic characteristics of pulmonary arterial endothelial cells (PAECs) play critical roles in pulmonary vascular remodeling and contribute to hypoxic pulmonary arterial hypertension (PAH ...
Xiaoming Li +15 more
doaj +1 more source
Bone morphogenic protein receptor 2 (BMPR2) expression and signaling are impaired in pulmonary arterial hypertension (PAH). How BMPR2 signaling is decreased in PAH is poorly understood.
Md Khadem Ali +7 more
doaj +1 more source

